Approval · Notice of Compliance 697 · 2002
NORITATE: Notice of Compliance 697
Issued February 4, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 697
- Date
- February 4, 2002
- Company
- Dermik Laboratories Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-rosacea agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORITATE | 02156091 | Marketed |
Medicinal ingredients
- METRONIDAZOLE 1 PER